Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDFRT and Temozolomide in Recurrent High Grade Glioma
NCT01466686Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2012
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in glioblastoma multiforme (GBM), anaplastic astrocytoma (AA), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Sep 2012; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on NCT01466686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466686.